Trial Profile
A Multicenter, Randomized, Placebo-controlled Phase II Trial to assess the effect of Daikenchuto (TJ-100) on Postoperative Bowel Motility and on Prevention of Paralytic Ileus after Pancreaticoduodenectomy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Mar 2017
Price :
$35
*
At a glance
- Drugs TU 100 (Primary)
- Indications Paralytic ileus
- Focus Therapeutic Use
- Acronyms JAPAN-PD
- 14 Mar 2017 New trial record